A Regression Analysis Of The Impact Of Patient Access Schemes

A Regression Analysis Of The Impact Of Patient Access Schemes

2013 Value in health

C | Volume: 16, Issue: 3, Pages: A268, analysis, market access agreements, patient access schemes, Regression Analysis,

Patient Access Schemes (PASs) are part of the UK Pharmaceutical Price Regulation Scheme (2009). PASs enable patients to receive drugs, and allow pharmaceutical companies to collect cost-effectiveness and efficacy data, even if the payer classified the drug as outside the cost-effectiveness threshold. This project analysed the effect of PASs on patient access (PA) (defined by total sales in volume/prevalence of the particular disease group).